A detailed history of Prudential Financial Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Prudential Financial Inc holds 37,221 shares of BLFS stock, worth $805,834. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,221
Previous 39,872 6.65%
Holding current value
$805,834
Previous $854,000 9.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$19.19 - $26.52 $50,872 - $70,304
-2,651 Reduced 6.65%
37,221 $931,000
Q2 2024

Aug 13, 2024

SELL
$15.14 - $22.99 $3,361 - $5,103
-222 Reduced 0.55%
39,872 $854,000
Q1 2024

May 14, 2024

SELL
$15.35 - $18.82 $6,032 - $7,396
-393 Reduced 0.97%
40,094 $743,000
Q4 2023

Feb 13, 2024

SELL
$8.99 - $16.86 $3,092 - $5,799
-344 Reduced 0.84%
40,487 $657,000
Q3 2023

Nov 13, 2023

SELL
$10.81 - $22.96 $26,884 - $57,101
-2,487 Reduced 5.74%
40,831 $563,000
Q2 2023

Aug 11, 2023

BUY
$17.19 - $24.34 $162,204 - $229,672
9,436 Added 27.85%
43,318 $957,000
Q1 2023

May 12, 2023

SELL
$17.67 - $26.07 $21,822 - $32,196
-1,235 Reduced 3.52%
33,882 $736,000
Q4 2022

Feb 14, 2023

BUY
$16.95 - $25.07 $1,288 - $1,905
76 Added 0.22%
35,117 $0
Q3 2022

Nov 04, 2022

BUY
$14.64 - $26.7 $48,180 - $87,869
3,291 Added 10.37%
35,041 $829,000
Q2 2022

Aug 15, 2022

BUY
$10.54 - $24.2 $13,259 - $30,443
1,258 Added 4.13%
31,750 $463,000
Q1 2022

May 13, 2022

SELL
$20.81 - $37.29 $617,037 - $1.11 Million
-29,651 Reduced 49.3%
30,492 $693,000
Q4 2021

Feb 14, 2022

BUY
$32.99 - $58.55 $962,318 - $1.71 Million
29,170 Added 94.18%
60,143 $2.88 Million
Q3 2021

Nov 15, 2021

BUY
$42.03 - $60.5 $1.3 Million - $1.87 Million
30,973 New
30,973 $1.47 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $924M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.